{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:27:38Z","timestamp":1791851258123,"version":"4.3.4"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1053\/j.semdp.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T20:46:08Z","timestamp":1511469968000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Immunohistochemistry, carcinomas of unknown primary, and incidence rates"],"prefix":"10.1053","volume":"35","author":[{"given":"Edward B.","family":"Stelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Yaziji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2017.11.012_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0000000000000069","article-title":"Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry","volume":"22","author":"Conner","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Pavlidis","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2017.11.012_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canep.2010.09.005","article-title":"Accuracy of cancer mortality study G: the accuracy of cancer mortality statistics based on death certificates in the United States","volume":"35","author":"German","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.semdp.2017.11.012_bib4","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1200\/JCO.2009.26.5983","article-title":"Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers","volume":"28","author":"Von Hoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/annonc\/mdw666","article-title":"Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial","volume":"28","author":"Belin","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2015.08.005","article-title":"Pathologic classification of neuroendocrine neoplasms","volume":"30","author":"Klimstra","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.semdp.2017.11.012_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","article-title":"Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry","volume":"20","author":"Bellizzi","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","article-title":"Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases","volume":"38","author":"Basturk","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.surg.2016.05.055","article-title":"Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors","volume":"161","author":"Keck","year":"2017","journal-title":"Surgery"},{"key":"10.1053\/j.semdp.2017.11.012_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archsurg.2010.10","article-title":"Identification of unknown primary tumors in patients with neuroendocrine liver metastases","volume":"145","author":"Wang","year":"2010","journal-title":"Arch Surg"},{"key":"10.1053\/j.semdp.2017.11.012_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00428-010-0954-0","article-title":"TTF1 expression in normal lung neuroendocrine cells and related tumors: immunohistochemical study comparing two different monoclonal antibodies","volume":"457","author":"La Rosa","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2017.11.012_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3880044","article-title":"Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors","volume":"13","author":"Agoff","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/hupa.2001.28245","article-title":"Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors","volume":"32","author":"Cai","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humpath.2004.02.016","article-title":"TTF-1 expression is specific for lung primary in typical and atypical carcinoids: ttf-1-positive carcinoids are predominantly in peripheral location","volume":"35","author":"Du","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib16","first-page":"5","article-title":"Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors","volume":"12","author":"Folpe","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/hupa.2002.31299","article-title":"Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids","volume":"33","author":"Sturm","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-001-0552-2","article-title":"Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases","volume":"440","author":"Zamecnik","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2017.11.012_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/PAS.0000000000000621","article-title":"Diagnostic utility of orthopedia homeobox (OTP) in pulmonary carcinoid tumors","volume":"40","author":"Nonaka","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12022-014-9346-3","article-title":"Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors","volume":"26","author":"Lai","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0b013e31826f042c","article-title":"Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases","volume":"37","author":"Graham","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2012.34","article-title":"Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin","volume":"25","author":"Koo","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X","article-title":"Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin","volume":"70","author":"Viale","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2017.11.012_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4132\/jptm.2017.03.19","article-title":"Loss of progesterone receptor expression is an early tumorigenesis event associated with tumor progression and shorter survival in pancreatic neuroendocrine tumor patients","volume":"51","author":"Kim","year":"2017","journal-title":"J Pathol Transl Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00418-011-0866-3","article-title":"Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors","volume":"136","author":"Lorenzo","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"10.1053\/j.semdp.2017.11.012_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12022-013-9264-9","article-title":"The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin","volume":"24","author":"Koo","year":"2013","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/01.pas.0000131531.75602.b9","article-title":"CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors","volume":"28","author":"Barbareschi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00428-004-1080-7","article-title":"CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors","volume":"445","author":"La Rosa","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2017.11.012_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.pai.0000210416.53493.0f","article-title":"Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin","volume":"15","author":"Lin","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0b013e31818d7d8b","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib31","first-page":"7072","article-title":"SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","article-title":"Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix","volume":"32","author":"Tang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib33","article-title":"Diagnostic utility of SATB2 in metastatic krukenberg tumors of the ovary: an immunohistochemical study of 70 cases with comparison to CDX2, CK7, CK20, chromogranin, and synaptophysin","author":"Yang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10147-013-0626-6","article-title":"Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors","volume":"19","author":"Brammer","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib35","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1053\/j.semdp.2017.11.012_bib36","unstructured":"https:\/\/www.cancer.org\/cancer\/small-cell-lung-cancer\/about\/key-statistics.html."},{"key":"10.1053\/j.semdp.2017.11.012_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/EP:15:3:247","article-title":"Cdx2 as a marker for neuroendocrine tumors of unknown primary sites","volume":"15","author":"Erickson","year":"2004","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00000478-199702000-00014","article-title":"Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites","volume":"21","author":"Chan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0046-8177(00)80199-9","article-title":"Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor","volume":"31","author":"Byrd-Gloster","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5858\/2001-125-0228-IFTTFA","article-title":"Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas","volume":"125","author":"Cheuk","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-0560.2000.027003118.x","article-title":"Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung","volume":"27","author":"Hanly","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00000478-200009000-00004","article-title":"Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas","volume":"24","author":"Ordonez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/PAS.0b013e3181aa30a5","article-title":"Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas","volume":"33","author":"Busam","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib44","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1172\/JCI64116","article-title":"Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus","volume":"122","author":"Rodig","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1053\/j.semdp.2017.11.012_bib45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ijc.24510","article-title":"Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors","volume":"125","author":"Shuda","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2017.11.012_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/PAS.0b013e3182698673","article-title":"Human papillomavirus-related carcinomas of the sinonasal tract","volume":"37","author":"Bishop","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/PAS.0b013e3182549b6d","article-title":"Detection of human papillomavirus in small cell carcinomas of the anus and rectum","volume":"36","author":"Cimino-Mathews","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PAS.0b013e31823f2f17","article-title":"HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior","volume":"36","author":"Kraft","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-199101000-00003","article-title":"Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer","volume":"15","author":"Stoler","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PAS.0000000000000580","article-title":"Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 Cases with an emphasis on HPV status","volume":"40","author":"Thompson","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.humpath.2014.12.012","article-title":"Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus","volume":"46","author":"Hartley","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(01)90072-7","article-title":"Molecular genetics of small cell lung carcinoma","volume":"28","author":"Wistuba","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semdp.2017.11.012_bib54","doi-asserted-by":"crossref","first-page":"e0121323","DOI":"10.1371\/journal.pone.0121323","article-title":"Lung cancer incidence trends by gender, race and histology in the United States, 1973\u20132010","volume":"10","author":"Meza","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2017.11.012_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","article-title":"Global incidence of oesophageal cancer by histological subtype in 2012","volume":"64","author":"Arnold","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.semdp.2017.11.012_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/PAI.0b013e3181ecaf1c","article-title":"Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases","volume":"19","author":"Pereira","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib57","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.30588","article-title":"Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases","volume":"123","author":"Berman","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2017.11.012_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/PAS.0000000000000454","article-title":"Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR)","volume":"39","author":"Dong","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.critrevonc.2014.09.002","article-title":"Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors","volume":"93","author":"Gadducci","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.semdp.2017.11.012_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12105-016-0692-y","article-title":"Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus","volume":"10","author":"Lewis","year":"2016","journal-title":"Head Neck Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12105-013-0514-4","article-title":"The sinonasal tract: another potential \"hot spot\" for carcinomas with transcriptionally-active human papillomavirus","volume":"8","author":"Lewis","year":"2014","journal-title":"Head Neck Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib62","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.31006","article-title":"group Vs: \"histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: a study of 1594 cases\"","volume":"141","author":"Rakislova","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2017.11.012_bib63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semdp.2014.12.018","article-title":"HPV- and non-HPV-related subtypes of penile squamous cell carcinoma (SCC): morphological features and differential diagnosis according to the new WHO classification (2015)","volume":"32","author":"Sanchez","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib64","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1038\/modpathol.2016.189","article-title":"Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems","volume":"30","author":"Chan","year":"2017","journal-title":"Mod Pathol"},{"issue":"711\u20136","key":"10.1053\/j.semdp.2017.11.012_bib65","article-title":"Uroplakin II (UPII), GATA3, and p40 are highly sensitive markers for the differential diagnosis of invasive urothelial carcinoma","volume":"23","author":"Hoang","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pathol.2016.05.008","article-title":"A combination ofp40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma","volume":"48","author":"Leivo","year":"2016","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.humpath.2014.09.007","article-title":"Utility of uroplakin II expression as a marker of urothelial carcinoma","volume":"46","author":"Tian","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1309\/AJCP0Q9UQTEESLHN","article-title":"Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas","volume":"141","author":"Liu","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib70","unstructured":"The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General Atlanta (GA) 2014."},{"key":"10.1053\/j.semdp.2017.11.012_bib71","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/0284186X.2017.1287944","article-title":"Lung cancer in never-smokers \u2013 what are the differences?","volume":"56","author":"Dias","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semdp.2017.11.012_bib72","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2009.06.014","article-title":"Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma","volume":"41","author":"Bishop","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/his.12383","article-title":"Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin","volume":"65","author":"Kim","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib75","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1309\/AJCPKVBXTI9O3TEM","article-title":"Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas","volume":"138","author":"Mukhopadhyay","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5858\/arpa.2011-0320-OA","article-title":"Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray","volume":"136","author":"Turner","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib77","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/AJCP8WO2EOIAHSOF","article-title":"The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary","volume":"142","author":"Kandalaft","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2014.61","article-title":"Napsin A is a specific marker for ovarian clear cell adenocarcinoma","volume":"28","author":"Yamashita","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.2004.01893.x","article-title":"Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade","volume":"45","author":"Jerome Marson","year":"2004","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib80","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000478-200206000-00010","article-title":"TTF-1 expression in pulmonary adenocarcinomas","volume":"26","author":"Yatabe","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib81","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib82","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/PAS.0b013e3181f884e8","article-title":"Thyroid transcription factor-1 expression in breast carcinomas","volume":"34","author":"Robens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib83","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib84","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/modpathol.3800205","article-title":"The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas","volume":"17","author":"Kaimaktchiev","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib85","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.MP.0000086073.92773.55","article-title":"Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays","volume":"16","author":"Moskaluk","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib86","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000478-200303000-00003","article-title":"CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas","volume":"27","author":"Werling","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib88","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.2575","article-title":"Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer","volume":"219","author":"Wang","year":"2009","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00019606-199704000-00003","article-title":"Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma","volume":"6","author":"Moskaluk","year":"1997","journal-title":"Diagn Mol Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib91","doi-asserted-by":"crossref","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2017.11.012_bib92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/14737159.2017.1308824","article-title":"The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring","volume":"17","author":"Openshaw","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1053\/j.semdp.2017.11.012_bib93","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PAI.0b013e31819faa07","article-title":"Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: a tissue microarray and pooled literature review study","volume":"17","author":"Wei","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/his.12645","article-title":"GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry","volume":"67","author":"Huo","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2559.2012.04344.x","article-title":"Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer","volume":"62","author":"Huo","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib96","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/AJCPMFR6OA8ICHNH","article-title":"Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin","volume":"135","author":"Lewis","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib97","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.3800731","article-title":"Breast-specific expression of MGB1\/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers","volume":"20","author":"Sasaki","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib98","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/modpathol.2010.38","article-title":"A study of immunohistochemical differential expression in pulmonary and mammary carcinomas","volume":"23","author":"Yang","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib99","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/PAS.0000000000000238","article-title":"Members of the IIiDUPG: best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib100","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","article-title":"NKX3.1 as a marker of prostatic origin in metastatic tumors","volume":"34","author":"Gurel","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.semdp.2005.11.001","article-title":"Immunohistochemistry in diagnostic surgical pathology of the prostate","volume":"22","author":"Hameed","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAP.0b013e3182862ac5","article-title":"Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management","volume":"20","author":"Shah","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib103","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib104","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib106","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib107","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison","volume":"136","author":"Ozcan","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib108","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study","volume":"22","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib109","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/his.12405","article-title":"Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody","volume":"65","author":"Toriyama","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","article-title":"WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium","volume":"23","author":"Acs","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib112","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2559.2004.02005.x","article-title":"WT-1 in ovarian and endometrioid serous carcinoma: a meta-analysis","volume":"46","author":"Heatley","year":"2005","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib115","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","article-title":"Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm","volume":"11","author":"Dennis","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2017.11.012_bib116","first-page":"184","article-title":"Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach","volume":"17","author":"DeYoung","year":"2000","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00129039-200006000-00006","article-title":"MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers","volume":"8","author":"Proca","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib118","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.3880134","article-title":"Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers","volume":"13","author":"Porcell","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib119","first-page":"25","article-title":"Clinical chemistry question and answer: What is the use of alpha-fetoprotein as a tumor marker?","volume":"2","author":"Stelow","year":"1999","journal-title":"J Intern Fed Clin Chem"},{"key":"10.1053\/j.semdp.2017.11.012_bib120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cncy.21184","article-title":"Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology","volume":"120","author":"McKnight","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1746-1596-7-149","article-title":"The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1","volume":"7","author":"Radwan","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib122","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1007\/s13277-014-3030-6","article-title":"Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma","volume":"36","author":"Sang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1053\/j.semdp.2017.11.012_bib123","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1309\/AJCPK1ZC9WNHCCMU","article-title":"Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens","volume":"138","author":"Timek","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib124","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/PAS.0b013e3181e5dffa","article-title":"Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms","volume":"34","author":"Yan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib125","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2169\/internalmedicine.55.6741","article-title":"Pancreatic hepatoid carcinoma mimicking a solid pseudopapillary neoplasm: a challenging case on endoscopic ultrasound-guided fine-needle aspiration","volume":"55","author":"Akimoto","year":"2016","journal-title":"Intern Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib126","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.humpath.2014.02.003","article-title":"Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma","volume":"45","author":"Osada","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib127","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dc.21075","article-title":"Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies","volume":"37","author":"Nassar","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00129039-200609000-00003","article-title":"Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics","volume":"14","author":"Wee","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib129","first-page":"494","article-title":"Cordon-cardo C: p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2017.11.012_bib130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.5858\/arpa.2013-0221-OA","article-title":"A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder","volume":"138","author":"Hoang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2017.11.012_bib131","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1309\/PYQC-17CB-063T-Q07J","article-title":"Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas","volume":"113","author":"Kaufmann","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib132","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1309\/AJCP1J0JPJBPSUXF","article-title":"Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants","volume":"142","author":"Li","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200301000-00001","article-title":"Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas","volume":"27","author":"Parker","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib134","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/his.12360","article-title":"Uroplakin II outperforms uroplakin III in diagnostically challenging settings","volume":"65","author":"Smith","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.012_bib135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.pai.0000213144.70148.8e","article-title":"Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications","volume":"15","author":"Bakshi","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2017.11.012_bib136","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/00000478-200112000-00003","article-title":"Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'","volume":"25","author":"McGregor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/AJCP8DMPEIMVH6YP","article-title":"Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas","volume":"140","author":"Pan","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib138","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181570343","article-title":"Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies","volume":"32","author":"Al-Ahmadie","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib139","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3182147fa8","article-title":"Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid","volume":"35","author":"Cimino-Mathews","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.012_bib140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.2012.538","article-title":"Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations","volume":"108","author":"Pinato","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semdp.2017.11.012_bib141","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/PAI.0000000000000004","article-title":"Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin","volume":"22","author":"Mentrikoski","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:40:48Z","timestamp":1659937248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257017301399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0740257017301399"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.012","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry, carcinomas of unknown primary, and incidence rates","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}